Table 1

Fraction affected (FA) and combination index (CI) of enzastaurin in combination with bortezomib, fluoarabine, and dexamethasone

Combination, doseFACI
Enzastaurin, μM/bortzomib, nM 
    2.5/5 0.15 1.072 
    2.5/10 0.45 0.838 
    5/5 0.27 0.921 
    5/10 0.56 0.757 
Enzastaurin, μM/fludarabine, μg/mL 
    5/5 0.62 0.676 
    7.5/5 0.74 0.695 
    5/10 0.77 0.524 
    7.5/10 0.81 0.63 
Enzastaurin, μM/dexamethasone, nM 
    7.5/50 0.42 0.895 
    10/50 0.71 0.969 
    7.5/100 0.45 0.877 
    10/100 0.74 0.945 
Combination, doseFACI
Enzastaurin, μM/bortzomib, nM 
    2.5/5 0.15 1.072 
    2.5/10 0.45 0.838 
    5/5 0.27 0.921 
    5/10 0.56 0.757 
Enzastaurin, μM/fludarabine, μg/mL 
    5/5 0.62 0.676 
    7.5/5 0.74 0.695 
    5/10 0.77 0.524 
    7.5/10 0.81 0.63 
Enzastaurin, μM/dexamethasone, nM 
    7.5/50 0.42 0.895 
    10/50 0.71 0.969 
    7.5/100 0.45 0.877 
    10/100 0.74 0.945 

All experiments were repeated at least twice.

Close Modal

or Create an Account

Close Modal
Close Modal